Emerging Roles of Gossypol in Therapy: Innovations in Prodrug Design and Nanoformulation Frontiers

Documenti analoghi

• Development of a Tumor Microenvironment‐Responsive Co(III)‐Chrysin Prodrug: Synthesis, Activation Profiling, and In Vitro Antineoplastic Evaluation
  di: Prakash Shukla, et al.
  Pubblicazione: (2025)
• Front Cover: Development of a Tumor Microenvironment‐Responsive Co(III)‐Chrysin Prodrug: Synthesis, Activation Profiling, and In Vitro Antineoplastic Evaluation (ChemMedChem 20/2025)
  di: Prakash Shukla, et al.
  Pubblicazione: (2025)
• Design of a Long‐Acting Morphine Prodrug for Safe Opioid Delivery
  di: Hana S. Alhamadsheh, et al.
  Pubblicazione: (2025)
• β‐Glucuronidase‐Responsive Albumin‐Binding Prodrug of Colchicine‐Site Binders for Selective Cancer Therapy
  di: Alexandra Bordes, et al.
  Pubblicazione: (2025)
• PROTAC‐Based HDAC Degradation: A Paradigm Shift in Targeted Epigenetic Therapies
  di: Ambati Himaja, et al.
  Pubblicazione: (2025)